1.The Effects of Antidepressants on the Energy Metabolism in LETO Rat.
Hyun Tae JEON ; Keun Ho JOE ; Young Kyun AHN ; Hong Tae KIM ; Baik Seok KEE
Korean Journal of Psychopharmacology 2009;20(4):194-204
Objectives : A diverse range of adverse effects has been linked to the application of antidepressants for the treatment of depressive disorder. Recently, evidence has been emerging of the adverse metabolic effects of antidepressants. This study investigated the effects of antidepressants on plasma glucose and other factors in the fat and muscle tissue relating to metabolism. METHODS : Long-Evans-Tokushima-Ostuka (LETO) rats were used to evaluate the effects of different antidepressants. Amitriptyline, fluoxetine, and mirtazapine were administered to each of three subgroups for 4 weeks, between 11 and 15 weeks old, while a fourth subgroup was administered no antidepressant during the same period. Changes of weight and daily intake were monitored. Tissues and blood were collected at 15 weeks. RESULTS : The fluoxetine subgroup showed lower weight gain and lower food efficacy ratio than did the other subgroups. Blood glucose and other circulating factors showed no significant differences among groups, except for the leptin levels of the fluoxetine subgroup. However, the amitriptyline and mirtazapine subgroups showed similar patterns in the response of mRNA expression of peroxisome proliferator-activated receptors gamma cofactor-1 and uncoupling protein-1, 2, 3. CONCLUSION : These results could indicate possible differences in metabolic response based on the kind of antidepressant used.
Amitriptyline
;
Animals
;
Antidepressive Agents
;
Blood Glucose
;
Depressive Disorder
;
Energy Metabolism
;
Fluoxetine
;
Glucose
;
Leptin
;
Mianserin
;
Muscles
;
Peroxisome Proliferator-Activated Receptors
;
Plasma
;
Rats
;
RNA, Messenger
;
Weight Gain
2.Determination of doxepin in whole blood by SPE-LC-MS/MS.
Fei-Jun GONG ; Song-Mao YAN ; Zhong-Ping WU ; Run-Sheng ZHANG
Journal of Forensic Medicine 2011;27(5):350-352
OBJECTIVE:
To develop a method of SPE-LC-MS/MS for the determination of doxepin in whole blood.
METHODS:
After solid phase extraction, the samples were identified by LC-MS/MS. Positive ion electrospray ionization mode and multiple reaction monitoring (MRM) mode was selected. Amitriptyline was used as internal standard. The m/z of doxepin: 280-->107, 280-->235 and 280-->220. The m/z of amitriptyline: 278-->233. The retaining time of doxepin and amitriptyline were 15.15 and 16.94 min, respectively.
RESULTS:
The calibration curve was linear among the concentration of doxepin range from 0.005 to 1.00 microg/mL. The linear correlation equation was y = 3.2047x + 0.0339, the correlation coefficient was 0.9996. The detection limit of doxepin was 0.001 microg/mL and average recovery rate was 78.0%-82.9%. The relative standard precision for within-day and between-day were less than 2.55% and 5.90%, respectively.
CONCLUSION
The method is effective, simple, reliable and can be used in the determination of doxepin in whole blood.
Amitriptyline/blood*
;
Antidepressive Agents, Tricyclic/poisoning*
;
Biomarkers/blood*
;
Chromatography, Liquid/methods*
;
Doxepin/poisoning*
;
Drug Overdose
;
Forensic Toxicology
;
Humans
;
Reproducibility of Results
;
Sensitivity and Specificity
;
Solid Phase Extraction/methods*
;
Spectrometry, Mass, Electrospray Ionization
;
Tandem Mass Spectrometry/methods*
3.Progress on painful diabetic peripheral neuropathy treated by integrative medicine.
Chinese Journal of Integrated Traditional and Western Medicine 2005;25(4):378-382
The article reviewed clinical studies on painful diabetic peripheral neuropathy (PDPN) treated by integrative medicine. PDPN, a common complication of diabetes mellitus, which could severely influence patients' quality of life. The keystone and difficulty of PDPN treatment is to relieve pain. Tricyclic anti-depressants are the firstline agents for neuropathic pain but with obvious adverse reactions. Antiepileptic drugs and capsicin can relieve PDPN with less adverse reactions. In recent years, lots of report of clinical studies on DPN treated by TCM or integrative medicine were issued, but those pertinent to PDPN were seldom. Only the papers with independent statistical analysis on effect of pain relieving were selected to review in this article, and the authors presumed that it is feasible to treat PDPN with integrative medicine.
Amines
;
therapeutic use
;
Amitriptyline
;
therapeutic use
;
Analgesics
;
therapeutic use
;
Animals
;
Antidepressive Agents, Tricyclic
;
therapeutic use
;
Blood Glucose
;
metabolism
;
Cyclohexanecarboxylic Acids
;
therapeutic use
;
Diabetic Neuropathies
;
complications
;
drug therapy
;
Drug Therapy, Combination
;
Drugs, Chinese Herbal
;
therapeutic use
;
Humans
;
Pain
;
drug therapy
;
etiology
;
Pain Measurement
;
Phytotherapy
;
Triazines
;
therapeutic use
;
gamma-Aminobutyric Acid
;
therapeutic use
4.Dalitong granule combined with electroacupuncture in the treatment of functional dyspepsia: A randomized controlled trial.
Chinese journal of integrative medicine 2015;21(10):743-750
OBJECTIVETo explore clinical short and long-term effect of combining dalitong granule (DG) and electroacupuncture group (EA) in the treatment of functional dyspepsia.
METHODSTotally 640 patients with confirmed functional dyspepsia were randomly divided into 4 groups using a randomized digital table: the DG group, the EA group, the combined group and the control group, 160 cases in each group. The DG group was treated with 6 g DG 3 times daily; the EA group was treated with puncture of points Zusanli (ST36), Zhongwan (CV12), Neiguan (PC6), Taichong (LR3) and Gongsun (SP4) twice daily; the combined group with above-mentioned DG and EA; and the control group with 5 mg mosapride 3 times, 20 mg pantoprazole and 25 mg amitriptylines twice daily. The treatment course was 4 weeks for all groups. The symptom score, quality of life score by Short Form 36 Health Survey Questionnaires (SF-36), plasma motilin by radioimmunoassay, electrogastrographic frequencies by electrogastrogram (EGG) and gastric emptying by B-sonography were examined, and adverse reactions were observed before, at the end of treatment and 60 weeks post-treatment.
RESULTSIn the DG group 1 case dropped out for not taking medicine strictly and 1 case was lost to follow-up, while 1 case in the EA group and 2 cases in the combined therapy group were lost to follow-up. Compared with pre-treatment, quality of life score, plasma motilin, electrogastrographic frequencies and gastric emptying were all increased significantly, while symptom score was decreased significantly at the end of treatment in each group (P<0.01); in the combined group quality of life score, plasma motilin, electrogastrographic frequencies and gastric emptying were all significantly higher than those in the other groups, while symptom score was significantly lower than in the other groups (P<0.05). Compared with at the end of treatment, these indices changed insignificantly in the combined group and the EA group 60 weeks post-treatment (P>0.05), but the 4 increased indices were all decreased significantly, and symptom score was increased significantly in the DG and the control groups (P>0.05). The short and long-term total effective rates in the combined group were all significantly higher than those in the other treatment groups (P<0.05 or P<0.01). No serious adverse reaction occurred in the four groups.
CONCLUSIONCombined treatment of DG and EA could increase both plasma motilin and electrogastrographic frequencies, promote gastric emptying, alleviate the symptom of dyspepsia so as to increase quality of life, with better safety and long-term effect.
Adult ; Amitriptyline ; administration & dosage ; Benzamides ; administration & dosage ; Combined Modality Therapy ; Drugs, Chinese Herbal ; administration & dosage ; therapeutic use ; Dyspepsia ; therapy ; Electroacupuncture ; Electrophysiology ; Female ; Gastric Emptying ; drug effects ; Gastrointestinal Agents ; administration & dosage ; Humans ; Male ; Morpholines ; administration & dosage ; Motilin ; blood ; Quality of Life ; Radioimmunoassay ; Sound Spectrography ; Stomach ; diagnostic imaging ; Ultrasonography